A Multicenter Double-blind Placebo-controlled Adaptive P

Project: Research project

Project Details

Description

A multicenter double blind placebo controlled adaptive Phase 3 trial of POL-103A polyvalent melanoma vaccine in post-resection melanoma patients with a high risk of recurrence
StatusActive
Effective start/end date1/1/121/1/21

Funding

  • POLYNOMA LLC

Fingerprint Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.